Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 68 clinical trials
Pharmacokinetics of Apixaban in Patients Undergoing Pancreaticoduodenectomy

Study investigators will examine the absorption characteristics of apixaban, a direct-acting oral anticoagulation, in patients who have underwent a particular kind of surgery

  • 0 views
  • 26 Jan, 2021
  • 1 location
Apixaban for Routine Management of Upper Extremity Deep Venous Thrombosis

This study will assess the safety and effectiveness of a drug called apixaban for the treatment of upper extremity deep vein thrombosis (UEDVT) and clinically important bleeding. Subjects will

heparin
apixaban 5 mg
deep vein thrombosis
clot
blood clot
  • 212 views
  • 23 Jan, 2021
  • 2 locations
RAMBLE - Rivaroxaban vs. Apixaban for Heavy Menstrual Bleeding

A large proportion of women with menstruating potential with newly diagnosed VTE or atrial fibrillation, treated with apixaban will have less menstrual blood loss than patients randomized to

anticoagulation therapy
rivaroxaban
apixaban
anticoagulants
  • 210 views
  • 23 Jan, 2021
  • 2 locations
Oral Anticoagulant Apixaban for Treatment of Venous Thromboembolism

Patients who have developed a venous thrombosis will receive apixaban to treat and prevent a secondary thromboembolism.

heparin
clot
thrombosis
apixaban
anticoagulant therapy
  • 2 views
  • 26 Jan, 2021
  • 1 location
Apixaban vs Enoxaparin Following Microsurgical Breast Reconstruction-An RCT

Subcutaneous enoxaparin is currently the gold standard for VTE chemoprophylaxis. However, the efficacy of chemoprophylaxis with subcutaneous enoxaparin is affected by patient-level factors, thus, resulting in VTE events despite guideline-compliant prophylaxis. A population at particular risk is the growing number of patients who undergo autologous breast reconstruction. Direct oral anticoagulants …

apixaban 2.5 mg
enoxaparin
apixaban
anesthesia
enoxaparin 40mg/0.4ml prefilled syringe
  • 0 views
  • 26 Jan, 2021
  • 1 location
Apixaban in Preventing Secondary Cancer Related Venous Thrombosis in Cancer Patients Who Have Completed Anticoagulation Therapy

This randomized phase III trial studies the best dose of apixaban and how well it works in preventing secondary cancer related venous thrombosis in cancer patients who have completed

anticoagulation therapy
positron emission tomography
blood clot
thrombosis
anticoagulant therapy
  • 121 views
  • 07 Mar, 2021
  • 38 locations
Efficacy and Safety of Apixaban in Reducing Restenosis and Limb Loss in PAD Patients.

This study will evaluate the efficacy and safety of apixaban 2.5 mg twice daily plus aspirin compared to the standard treatment (clopidogrel plus aspirin) in patients with critical limb ischemia

endovascular intervention
limb ischemia
serum pregnancy test
clopidogrel
stenosis
  • 0 views
  • 23 Jan, 2021
  • 1 location
Apixaban Warfarin and Aspirin Prevents Portal Vein Thrombosis in Patients After Laparoscopic Splenectomy ESAWAAPT

The purpose of this study is to determine whether Apixaban, Warfarin and Aspirin Anticoagulation are effective and safe in Prevention of Portal Vein Thrombosis in Liver Cirrhotic Patients after

  • 0 views
  • 28 Jan, 2021
  • 1 location
Assessing Feasibility of Thromboprophylaxis With Apixaban in JAK2-positive Myeloproliferative Neoplasm Patients

physicians decide the best treatment plan for these patients. The study drug, apixaban, is a new type of orally-taken blood thinner that has been shown to be effective and safe for prevention and

  • 0 views
  • 07 Mar, 2021
  • 1 location
A Prospective Multi-dose Study of Apixaban in Subjects With Nephrotic Syndrome

This phase I study is a single arm, multi-dose study that will evaluate steady-state apixaban pharmacokinetics (PK) and pharmacodynamics (PD) in subjects with Nephrotic Syndrome (NS) vs healthy

  • 0 views
  • 07 Mar, 2021
  • 1 location